Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRWD0715 in Healthy Volunteers and Axial Spondyloarthritis
NCT07047703Phase 2Recruiting
- Sponsor
- Grey Wolf Therapeutics
- Start
- Jul 2025
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of GRWD0715 in axial spondyloarthritis (axSpA), sponsored by Grey Wolf Therapeutics. Started Jul 2025; status: recruiting.
02
Drugs
GRWD0715
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT07047703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07047703.